With 23andMe in ‘financial distress,’ California official issues alert to customers
By Jason Green,
The Mercury News
| 03. 24. 2025
With genetic testing company 23andMe facing an increasingly uncertain future, California Attorney General Rob Bonta on Friday reminded customers they have the right to tell the firm to permanently delete their data.
The South San Francisco-based company has publicly reported it is in “financial distress” and stated in recent securities filings that there is substantial doubt about its ability to keep going, the California Attorney General’s Office said in a news release.
The “trove of sensitive consumer data” amassed by 23andMe is subject to deletion under both the Genetic Information Privacy Act and the California Consumer Protection Act, according to the office.
“California has robust privacy laws that allow consumers to take control and request that a company delete their genetic data,” Bonta said in a statement. “Given 23andMe’s reported financial distress, I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company.”
Customers can delete their 23andMe account and personal information by taking the following steps:
- Log into your 23andMe account on the...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...